EcoDrugPlus

Glutamate Receptor 2-Like

Ensembl ID : ENSACLG00000013254
Gene Symbol: LOC113024706
3 Cross references
244 Possible Orthologues:

Glutamate Receptor 3

Ensembl ID : ENSACLG00000012137
Gene Symbol: LOC113030021
3 Cross references
254 Possible Orthologues:

Glutamate Receptor 4

Ensembl ID : ENSACLG00000022681
Gene Symbol: LOC113030745
3 Cross references
252 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSACLG00000021986
Gene Symbol: LOC113032874
2 Cross references
213 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 3b-Like

Ensembl ID : ENSACLG00000007070
Gene Symbol: LOC113011845
2 Cross references
227 Possible Orthologues:

Glutamate Receptor Ionotropic, Kainate 2-Like

Ensembl ID : ENSACLG00000021584
Gene Symbol: LOC113037170
2 Cross references
254 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSACLG00000024196
Gene Symbol: GRM3
1 Cross references
212 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSACLG00000013667
Gene Symbol: LOC113016065
3 Cross references
236 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSACLG00000001867
Gene Symbol: LOC113008514
2 Cross references
225 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSACLG00000004350
Gene Symbol: GSK3B
3 Cross references
208 Possible Orthologues:

Glycogen Synthase Kinase-3 Alpha-Like

Ensembl ID : ENSACLG00000026113
Gene Symbol: LOC113032794
3 Cross references
187 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSACLG00000021016
Gene Symbol: LOC113014387
3 Cross references
181 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).